I am so furious and fed up with the FDA when it comes to approving PD treatments! WTH?

Duodopa has been used successfully in Europe for at least 5 years, not to mention the whole concept of direct delivery into the small intestine has been around at least 20 years- yes folks, this concept was first explored; what is so different about using it here? Are they telling us Europeans and Americans have such vastly different anatomy that years of testing is required here? I find it unconscionable that this is not at the very least fast tracked. This makes me highly suspect that Medtronic doesn't have something to do with its delay? If we have Duodopa as an interim or alternate to DBS, how much business will Medtronic lose? If this has to do with nationalism in the sense that our tests are required as we set the bar higher...I'm not at all convinced.

Laura